Semafore Pharmaceuticals
Indianapolis
About Semafore Pharmaceuticals
Semafore Pharmaceuticals is a development-stage drug discovery company that targets the PI3K cell signaling pathways to create anti-cancer drugs. Their PI3K inhibitors are used to treat tumors and have the potential to treat cancers of the brain, lungs, and hemological systems.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $13.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2007)
- Website: semaforepharma.com
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/semafore-pharmaceuticals-2856671 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.